Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Core study information appears unchanged; updates are limited to metadata such as the last updated date.
    Difference
    0.1%
    Check dated 2026-04-01T22:38:57.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added the condition Myelodysplastic/myeloproliferative neoplasm and removed Myeloproliferative neoplasm from the Conditions list; page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:05:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-03-18T11:58:47.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to the page content.
    Difference
    0.1%
    Check dated 2026-03-11T14:22:34.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T10:43:15.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The update appears to be minor visual or formatting adjustments to the study page without altering the actual study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T04:15:05.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.